
|Articles|September 12, 2006
MICS has made very little impact on US and EU surgeon practice
Microincision cataract surgery (MICS), hailed to be the next big development in cataract surgery, has not had the expected impact on surgeon's practice, David Leaming revealed, whilst detailing the results of his most recent survey on cataract surgery practice in Europe and the US.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: Updates on tinlarebant in adolescent Stargardt disease
2
Macular laser picks up speed: The technology accelerating retinal therapies
3
FLORetina 2025: Long-term follow-up in paediatric gene therapy
4
FLORetina 2025: Enrico Borrelli on reframing retinal disease through the lens of choroidal health
5












































